Pexidartinib (PEX,TURALIO), a selective and potent inhibitor ofthe macrophage colony-stimulating factor-1 receptor, has been approvedfor the treatment of tenosynovial giant cell tumor. This evidence concerns the gene CSF1R and tenosynovial giant cell tumor.